Cervical intraepithelial neoplasia
Also known as: CIN, Cervical dysplasia, Cervical squamous intraepithelial neoplasia, Cervical precancerous changes
Cervical intraepithelial neoplasia (CIN) denotes dysplastic alterations within the squamous epithelium of the cervix, typically associated with persistent high-risk human papillomavirus (HPV) infection. CIN is not invasive cancer; histological grading and individual clinical circumstances guide surveillance or treatment. Cited evidence focuses on diagnostic triage, related vaginal lesions, and post-excision recurrence risk rather than traditional Chinese medicine (TCM) efficacy. Current clinical data do not support the use of acupuncture or Chinese herbal medicine for the regression of CIN, clearance of HPV, or prevention of recurrence. Practitioner-led TCM is restricted to adjunctive management of comorbid symptoms or psychological distress. TCM interventions must not delay colposcopy, biopsy, indicated excision, vaccination discussions, or scheduled HPV surveillance, as symptomatic improvement does not correlate with histological resolution.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain a comprehensive record of all HPV, cytology, and biopsy results, including the scheduled date for subsequent surveillance.
- •Utilise smoking-cessation resources; cited evidence indicates tobacco use is associated with elevated recurrence rates following large loop excision of the transformation zone (LEEP).
- •Consult a medical practitioner regarding HPV vaccination eligibility, noting that vaccination does not replace surveillance or treat an existing lesion.
- •Strictly adhere to specialist post-procedural protocols concerning physical exertion, coitus, and the avoidance of intravaginal products.
Cautions & Contraindications
- •Do not postpone indicated colposcopy or biopsy because symptoms improve or a TCM pattern appears resolved. Diagnostic testing, not tongue or pulse findings, establishes clinically significant cervical lesions.[]
- •Do not replace post-LEEP surveillance with acupuncture or herbal treatment, particularly with persistent high-risk HPV, positive margins or higher-grade disease.[]
- •Do not use the fertility-clinic TCM utilisation study to justify herbal or needling safety in pregnancy or to claim CIN benefit: it evaluated utilisation associations, not these questions.[]
When to reassess or seek care again
Review adjunctive care after 2–4 weeks using the same patient-rated 0–10 symptom scores, sleep disruption frequency and relevant functional goals. Check adverse effects and attendance at scheduled cervical follow-up at every visit. Stop or revise adjunctive treatment if there is no meaningful symptom benefit by 4–6 weeks. New bleeding, persistent pain, abnormal results without a management plan or missed surveillance require medical referral; acute severe symptoms require urgent escalation. Only the treating service's HPV, cytology, colposcopy and histology pathway can assess cervical disease status.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Acta obstetricia et gynecologica Scandinavica · 2026
- Medicine · 2026
- F&S reports · 2026
- BMC women's health · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
